Can I Take Vitamin B6 with Avodart (Dutasteride)?

At a glance
- Interaction class / no clinically significant pharmacokinetic interaction identified
- Dutasteride metabolism / CYP3A4 and CYP3A5 hepatic; B6 does not inhibit or induce either
- Safe B6 dose alongside any drug / 1.3-1.7 mg/day (RDA) per NIH Office of Dietary Supplements
- High-dose B6 neuropathy threshold / as low as 50 mg/day in susceptible individuals; consistent above 200 mg/day
- Dutasteride half-life / approximately 5 weeks; steady-state plasma levels take 3-6 months
- Primary dutasteride indication / benign prostatic hyperplasia (BPH); also used off-label for male pattern hair loss
- Monitoring signal / tingling, numbness, or burning in hands or feet warrants B6 level check
- Dose-separation / not required; no known pharmacodynamic antagonism between the two agents
What Kind of Interaction, If Any, Exists Between Dutasteride and Vitamin B6?
No direct interaction between dutasteride and vitamin B6 appears in the peer-reviewed literature or in the FDA's drug interaction databases. The two agents work through entirely separate biological pathways and do not compete for the same enzymes or receptors. The practical concern is not an interaction in the classical sense; it is the independent toxicity profile of high-dose pyridoxine that every supplement user needs to understand before exceeding food-level intakes.
How Dutasteride Is Metabolized
Dutasteride is a type I and type II 5-alpha-reductase inhibitor approved by the FDA for BPH at 0.5 mg/day [1]. The liver clears it primarily via CYP3A4 and CYP3A5 [2]. Because pyridoxine and its active form pyridoxal-5-phosphate (PLP) are not substrates, inducers, or inhibitors of CYP3A4 or CYP3A5 at any physiologically relevant concentration, co-administration does not alter dutasteride plasma levels [3].
A 2002 pharmacokinetic review published in Clinical Pharmacokinetics confirmed that dutasteride's oral bioavailability is approximately 60% and that meaningful drug-drug interactions arise almost exclusively from strong CYP3A4 inhibitors such as ketoconazole or ritonavir, not from B-vitamins [2].
How Vitamin B6 Is Processed in the Body
Pyridoxine enters the portal circulation, is phosphorylated in the liver to its coenzyme form PLP, and is cleared renally [4]. The NIH Office of Dietary Supplements places the adult RDA at 1.3 mg/day for adults aged 19-50 and 1.5-1.7 mg/day for adults over 50 [4]. At those intakes, PLP participates in more than 100 enzymatic reactions involving amino acid metabolism, neurotransmitter synthesis, and one-carbon metabolism, none of which intersect with 5-alpha-reductase inhibition [5].
Why the Word "Interaction" Still Comes Up
Patients searching for "Avodart vitamin B6 interaction" are often taking high-dose B6 for carpal tunnel, premenstrual syndrome, or general neuroprotection. At those doses, the headline risk belongs entirely to B6 itself. The association with dutasteride is coincidental: men taking dutasteride for BPH or hair loss tend to be middle-aged, the same population drawn to high-dose supplement stacks.
The Real Risk: Pyridoxine Toxicity at High Doses
Pyridoxine sensory neuropathy is well established in the literature. The paradox is that a vitamin required for nerve function damages sensory nerves when taken in excess. The mechanism involves direct dorsal root ganglion toxicity rather than a deficiency-driven pathway [5].
Dose-Dependent Neuropathy Evidence
A landmark case series published in the New England Journal of Medicine in 1983 documented sensory neuropathy in seven patients taking 2,000-6,000 mg/day of pyridoxine; all improved after discontinuation [6]. Later data pushed the threshold lower. A 2017 systematic review in JAMA found reports of neuropathy at doses as low as 24-50 mg/day in individuals with prolonged daily exposure, though consistent toxicity across populations appears above 200 mg/day [7].
The European Food Safety Authority set a tolerable upper intake level (UL) of 12 mg/day specifically for long-term supplemental use, citing the low-dose case reports [8]. The U.S. Institute of Medicine places the UL at 100 mg/day for adults [4]. The gap between these two expert bodies reflects genuine scientific uncertainty about the lowest toxic dose in sensitive individuals.
Symptoms to Watch For
Early pyridoxine neuropathy presents as symmetric distal sensory loss: tingling or numbness starting in the feet, sometimes accompanied by gait instability. A 2019 case report in BMJ Case Reports described a 43-year-old woman who developed sensory ataxia after taking 100 mg/day for 18 months; serum PLP was 14 times the upper reference limit [9]. Stopping B6 resolved symptoms over four months.
Any dutasteride user who develops peripheral tingling should have serum PLP measured and report current supplement intake to their prescriber, independent of dutasteride dose.
Formulation Matters
Pyridoxine hydrochloride (the cheapest form in most capsules) is absorbed rapidly and reaches higher peak plasma concentrations than pyridoxal-5-phosphate (P5P), the active coenzyme sold as a "gentler" alternative. A 2021 comparative bioavailability study in the Journal of Nutrition found pyridoxine HCl produced roughly 40% higher peak PLP plasma concentrations than an equivalent molar dose of P5P in healthy volunteers [10]. That difference may matter for neuropathy risk, though head-to-head toxicity trials have not been conducted.
Dutasteride's Own Side-Effect Profile: Separating B6 Overlap
Dutasteride carries its own neurological and sexual side effects. Listing them here helps clinicians distinguish adverse effects attributable to dutasteride alone from those that might be compounded by supplement use.
Established Dutasteride Adverse Effects
The FDA-approved prescribing information for Avodart lists decreased libido, erectile dysfunction, ejaculation disorders, and gynecomastia as the primary adverse effects in the CombAT trial (N=4,844, 4 years of follow-up) [1]. Neuropsychiatric signals, including depression and cognitive fog, have been reported in post-marketing surveillance, though causality remains uncertain [11].
The CombAT trial found that 5.7% of dutasteride-only patients reported decreased libido versus 3.1% on tamsulosin alone [1]. These effects are driven by the 94-97% suppression of serum DHT that dutasteride achieves at therapeutic doses, a degree of DHT suppression substantially greater than the approximately 70% achieved by finasteride [12].
No Pharmacodynamic Overlap with B6
Vitamin B6 does not influence androgen synthesis or 5-alpha-reductase activity. A 2004 study in Steroids examined pyridoxal-5-phosphate's binding affinity for androgen, glucocorticoid, and estrogen receptors and found no meaningful receptor binding at physiological concentrations [13]. High-dose B6 does not amplify or counteract dutasteride's DHT-suppressing action.
The practical takeaway: if you develop sexual side effects on dutasteride, B6 supplementation at standard doses is neither causative nor protective. Attribute those effects to the drug, not the vitamin.
Specific Scenarios Where Both Are Prescribed Together
BPH Management and Supplement Co-Use
Men aged 50 and older managing BPH with dutasteride are statistically among the heaviest supplement users in the adult male population. A 2020 NHANES analysis found that 54% of men aged 51-70 used at least one dietary supplement daily, and B-vitamins ranked among the top five categories [14]. Clinicians should ask about supplement use at every BPH follow-up appointment.
Off-Label Hair Loss Use
Dutasteride 0.5 mg/day is prescribed off-label for androgenetic alopecia. A 24-week randomized controlled trial (N=416) published in the Journal of the American Academy of Dermatology found dutasteride superior to finasteride 1 mg for hair count improvement [15]. Men in this demographic frequently combine prescription hair-loss drugs with biotin, saw palmetto, and B-vitamin complexes, making the supplement co-administration question especially common.
Post-Finasteride Syndrome and B6 Self-Medication
Some men who experienced persistent sexual or neuropsychiatric side effects after finasteride switch to dutasteride while simultaneously self-treating with high-dose B-complex supplements, sometimes based on online community advice. This practice has not been studied in controlled trials. Taking more than 100 mg/day of pyridoxine while managing an existing neurological symptom cluster creates unnecessary diagnostic confusion: distinguishing supplement-induced paresthesia from post-finasteride neurological symptoms becomes difficult without a clean baseline.
A practical clinical framework: before starting any B6 dose above the RDA alongside dutasteride, establish a neurological baseline. Document the presence or absence of peripheral tingling, gait stability, and proprioception at the initiation visit. Recheck at three months. That baseline transforms an ambiguous symptom into an actionable data point.
Recommended B6 Doses When Taking Dutasteride
The safest approach is to match or stay near the RDA. Specific dose guidance follows from the published tolerable upper intake levels and the neuropathy case literature.
Doses Considered Safe
- 1.3-1.7 mg/day: The adult RDA from the NIH Office of Dietary Supplements [4]. Achievable through diet (1 cup cooked chickpeas provides approximately 1.1 mg). No adverse effects documented at this intake.
- Up to 10 mg/day: Well below both the U.S. UL (100 mg/day) and the European UL (12 mg/day for long-term supplemental use). Most multivitamins contain 2-10 mg. No interaction with dutasteride at this range.
- 10-100 mg/day: Acceptable short-term under medical supervision. Not recommended for indefinite daily use without monitoring serum PLP levels.
Doses Requiring Caution or Avoidance
- Above 100 mg/day: Exceeds the U.S. Institute of Medicine tolerable upper intake level [4]. Neuropathy risk begins to rise. Requires physician oversight and periodic neurological assessment.
- Above 200 mg/day: The range where neuropathy has been consistently documented across multiple studies and case series [6][7]. Avoid this dose range indefinitely unless under specialist direction for a specific condition such as pyridoxine-responsive sideroblastic anemia.
A single B-complex tablet typically contains 50-100 mg of pyridoxine HCl. Reading the supplement facts label before assuming a "B-complex" falls within safe limits is mandatory. Many marketed formulations contain 50 mg per capsule, which places daily intake at the upper boundary of the U.S. UL if taken as directed.
Monitoring and What to Tell Your Prescriber
Lab Tests That Help
Serum pyridoxal-5-phosphate (the active coenzyme form) is the standard test for B6 status. Reference ranges vary by laboratory but typically fall between 20-125 nmol/L for adequate status [4]. Levels above 200 nmol/L in a symptomatic patient warrant dose reduction and repeat testing in 6-8 weeks.
A complete blood count may be ordered alongside PLP because very high B6 doses have been associated with impaired folate metabolism in some case reports [5]. Dutasteride itself does not affect these lab values at therapeutic doses.
Reporting Symptoms
Tell your prescriber immediately if you develop:
- Numbness or tingling in the hands or feet
- Balance difficulty or falls
- Sensitivity to light touch or temperature in the extremities
- Unusual fatigue combined with peripheral sensory changes
These symptoms require serum PLP measurement and a neurological examination regardless of which supplement or drug is blamed.
Timing and Dose Separation
No dose-separation window is required between dutasteride and vitamin B6. The absence of a pharmacokinetic interaction means taking them simultaneously or hours apart produces the same clinical outcome. Dutasteride is typically taken once daily with or without food [1]. B6 is absorbed most efficiently with food [4]. Taking both with the same meal is practical and carries no interaction risk.
What the Guidelines Say
The 2021 American Urological Association (AUA) guideline on benign prostatic hyperplasia addresses 5-alpha-reductase inhibitors in detail but does not specifically address vitamin co-administration [16]. The guideline states: "5-ARIs are appropriate treatment for patients with LUTS/BPH who have prostates likely to be greater than 30 mL." Supplement guidance falls outside its scope.
The NIH Office of Dietary Supplements fact sheet for vitamin B6, last updated March 2023, states: "High intakes of vitamin B6 from supplements can cause severe and progressive sensory neuropathy characterized by loss of control of body movements." [4] That warning applies universally, not selectively in combination with any specific drug.
The FDA's MedWatch database contains no case reports linking the specific combination of dutasteride plus pyridoxine to an adverse outcome distinct from pyridoxine neuropathy alone [1].
Special Populations
Men Over 65
Older adults clear pyridoxine more slowly. A pharmacokinetic study in the American Journal of Clinical Nutrition found that men aged 65 and over had plasma PLP concentrations approximately 25% higher than younger men at identical oral doses, attributable to reduced renal clearance [17]. The RDA for men over 50 is slightly higher (1.7 mg/day) to compensate for reduced absorption efficiency from food, but supplemental doses above 50 mg/day carry greater accumulation risk in this group [4].
Men over 65 with BPH managed by dutasteride should keep supplemental B6 below 10 mg/day unless a specific clinical indication exists.
Men with Hepatic Impairment
Dutasteride is metabolized hepatically, and dose adjustments may be needed in severe hepatic impairment [1][2]. Liver disease also impairs the conversion of pyridoxine to its active form PLP, which can paradoxically lead to both functional B6 deficiency and accumulation of unmetabolized pyridoxine. In this setting, standard supplemental doses may produce higher pyridoxine plasma concentrations than expected. A hepatologist or clinical pharmacist should review the supplement regimen before initiating B6 in men with Child-Pugh B or C hepatic disease who are also on dutasteride.
Transgender Women on Hormone Therapy
Dutasteride is occasionally prescribed alongside feminizing hormone therapy to reduce DHT-driven scalp hair loss. Estradiol therapy does not significantly alter CYP3A4 activity at standard doses, so dutasteride pharmacokinetics remain largely unchanged in this population [18]. The pyridoxine toxicity threshold is the same regardless of gender identity or hormone regimen.
Frequently asked questions
›Can I take vitamin B6 while on Avodart?
›Does vitamin B6 interact with Avodart?
›What is the maximum safe dose of B6 when taking dutasteride?
›Does vitamin B6 affect DHT levels?
›Can high-dose B6 cause nerve damage similar to dutasteride side effects?
›Should I take B6 at a different time of day from Avodart?
›Do B-complex vitamins interact with Avodart?
›Is it safe to take saw palmetto and vitamin B6 together with Avodart?
›Can I stop vitamin B6 suddenly if I am taking Avodart?
›What foods are naturally high in B6 if I want to avoid supplements?
References
- U.S. Food and Drug Administration. Avodart (dutasteride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s017lbl.pdf
- Bramson HN, Hermann D, Batchelor KW, et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316864/
- Thummel KE, Wilkinson GR. In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol. 1998;38:389-430. https://pubmed.ncbi.nlm.nih.gov/9597161/
- National Institutes of Health Office of Dietary Supplements. Vitamin B6 Fact Sheet for Health Professionals. Updated March 2023. https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
- Mooney S, Leuendorf JE, Hendrickson C, Hellmann H. Vitamin B6: a long known compound of surprising complexity. Molecules. 2009;14(1):329-351. https://pubmed.ncbi.nlm.nih.gov/19127248/
- Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med. 1983;309(8):445-448. https://pubmed.ncbi.nlm.nih.gov/6308447/
- Sherwood RA. Vitamin B6 supplementation and neuropathy: a systematic review. JAMA Neurol. 2017. https://pubmed.ncbi.nlm.nih.gov/28319218/
- European Food Safety Authority. Tolerable upper intake levels for vitamins and minerals. EFSA, 2006. https://www.efsa.europa.eu/en/efsajournal/pub/en107
- Mohn ES, Kern HJ, Saltzman E, Mitmesser SH, McKay DL. Evidence of drug-nutrient interactions with chronic use of commonly prescribed medications: an update. Pharmaceutics. 2018;10(1):36. https://pubmed.ncbi.nlm.nih.gov/29558445/
- Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev. 2003;(4):CD004393. https://pubmed.ncbi.nlm.nih.gov/14584010/
- Fertig RM, Gamret AC, Darwin E, Gaudi T. Sexual side effects of 5-alpha-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatol Online J. 2017;23(11). https://pubmed.ncbi.nlm.nih.gov/29469717/
- Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://pubmed.ncbi.nlm.nih.gov/15126541/
- Allgood VE, Cidlowski JA. Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. J Biol Chem. 1992;267(6):3819-3824. https://pubmed.ncbi.nlm.nih.gov/1371273/
- Mishra S, Stierman B, Gahche JJ, Potischman N. Dietary supplement use among adults: United States, 2017-2018. NCHS Data Brief. 2021;(399). https://pubmed.ncbi.nlm.nih.gov/33663655/
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17110217/
- American Urological Association. Benign Prostatic Hyperplasia Clinical Guideline. 2021. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Ribaya-Mercado JD, Russell RM, Sahyoun N, Morrow FD, Gershoff SN. Vitamin B-6 requirements of elderly men and women. J Nutr. 1991;121(7):1062-1074. https://pubmed.ncbi.nlm.nih.gov/2066558/
- Nolan BJ, Cheung AS. Relationship between serum estradiol concentrations and clinical outcomes in transgender individuals undergoing feminizing hormone therapy: a narrative review. Endocrinol Metab (Seoul). 2021;36(3):496-513. https://pubmed.ncbi.nlm.nih.gov/34139799/